Credit Suisse’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-128,181
| Closed | -$6.62M | – | 4237 |
|
|
2022
Q3 | $6.62M | Buy |
128,181
+79,418
| +163% | +$3.28M | 0.01% | 1111 |
|
|
2022
Q2 | $1.21M | Sell |
48,763
-320
| -0.7% | -$7.05K | ﹤0.01% | 2256 |
|
|
2022
Q1 | $1.23M | Sell |
49,083
-793
| -2% | -$22.3K | ﹤0.01% | 2413 |
|
|
2021
Q4 | $1.82M | Sell |
49,876
-12,465
| -20% | -$438K | ﹤0.01% | 2865 |
|
|
2021
Q3 | $1.07M | Buy |
62,341
+22,451
| +56% | +$350K | ﹤0.01% | 3290 |
|
|
2021
Q2 | $534K | Sell |
39,890
-5,161
| -11% | -$127K | ﹤0.01% | 3802 |
|
|
2021
Q1 | $2.31M | Sell |
45,051
-38,632
| -46% | -$2.32M | ﹤0.01% | 2705 |
|
|
2020
Q4 | $5.18M | Buy |
83,683
+17,970
| +27% | +$1.03M | ﹤0.01% | 2063 |
|
|
2020
Q3 | $3.6M | Sell |
65,713
-5,238
| -7% | -$282K | ﹤0.01% | 2003 |
|
|
2020
Q2 | $4.08M | Buy |
70,951
+49,086
| +224% | +$2.67M | ﹤0.01% | 1838 |
|
|
2020
Q1 | $878K | Sell |
21,865
-5,178
| -19% | -$220K | ﹤0.01% | 2762 |
|
|
2019
Q4 | $1.07M | Buy |
27,043
+9,393
| +53% | +$165K | ﹤0.01% | 3071 |
|
|
2019
Q3 | $120K | Sell |
17,650
-182
| -1% | -$1.37K | ﹤0.01% | 3949 |
|
|
2019
Q2 | $166K | Buy |
17,832
+4,779
| +37% | +$55.3K | ﹤0.01% | 3882 |
|
|
2019
Q1 | $181K | Buy |
13,053
+2,635
| +25% | +$30.1K | ﹤0.01% | 3784 |
|
|
2018
Q4 | $114K | Buy |
+10,418
| New | +$110K | ﹤0.01% | 3755 |
|
|
2018
Q3 | – | Sell |
-14,279
| Closed | -$187K | – | 4062 |
|
|
2018
Q2 | $187K | Buy |
14,279
+1,010
| +8% | +$12.1K | ﹤0.01% | 3779 |
|
|
2018
Q1 | $180K | Buy |
13,269
+1,944
| +17% | +$20.1K | ﹤0.01% | 3722 |
|
|
2017
Q4 | $67K | Sell |
11,325
-6,715
| -37% | -$46.1K | ﹤0.01% | 3889 |
|
|
2017
Q3 | $134K | Buy |
+18,040
| New | +$150K | ﹤0.01% | 4031 |
|
|
2017
Q1 | – | Sell |
-26,835
| Closed | -$198K | – | 4150 |
|
|
2016
Q4 | $198K | Buy |
26,835
+5,475
| +26% | +$39.4K | ﹤0.01% | 3818 |
|
|
2016
Q3 | $129K | Sell |
21,360
-11,621
| -35% | -$54.9K | ﹤0.01% | 3893 |
|
|
2016
Q2 | $148K | Sell |
32,981
-733,015
| -96% | -$2.75M | ﹤0.01% | 3974 |
|
|
2016
Q1 | $1.91M | Buy |
765,996
+271,384
| +55% | +$988K | ﹤0.01% | 2246 |
|
|
2015
Q4 | $4.01M | Buy |
494,612
+380,506
| +333% | +$2.69M | ﹤0.01% | 1756 |
|
|
2015
Q3 | $691K | Buy |
114,106
+63,929
| +127% | +$462K | ﹤0.01% | 3150 |
|
|
2015
Q2 | $413K | Buy |
50,177
+23,192
| +86% | +$184K | ﹤0.01% | 3840 |
|
|
2015
Q1 | $203K | Sell |
26,985
-21,126
| -44% | -$165K | ﹤0.01% | 4081 |
|
|
2014
Q4 | $328K | Buy |
48,111
+26,816
| +126% | +$142K | ﹤0.01% | 3999 |
|
|
2014
Q3 | $96K | Buy |
21,295
+826
| +4% | +$4.37K | ﹤0.01% | 4302 |
|
|
2014
Q2 | $119K | Sell |
20,469
-22,964
| -53% | -$129K | ﹤0.01% | 4506 |
|
|
2014
Q1 | $289K | Sell |
43,433
-38,901
| -47% | -$270K | ﹤0.01% | 4135 |
|
|
2013
Q4 | $476K | Sell |
82,334
-81,203
| -50% | -$419K | ﹤0.01% | 3805 |
|
|
2013
Q3 | $909K | Buy |
163,537
+139,675
| +585% | +$1.51M | ﹤0.01% | 3044 |
|
|
2013
Q2 | $338K | Buy |
+23,862
| New | +$309K | ﹤0.01% | 3557 |
|
Other funds holding CCXI
Credit Suisse's CCXI Position: Q4 2022 in Review
Credit Suisse sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 128,181 shares — an estimated $6.62M sold.
Credit Suisse first reported a position in CCXI in Q2 2013 and held it in 35 quarters. The position peaked at $6.62M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Credit Suisse reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Credit Suisse sold 128,181 ChemoCentryx, Inc. shares in Q4 2022, an estimated $6.62M.
- Credit Suisse first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 35 quarters.
- Credit Suisse's ChemoCentryx, Inc. position peaked at $6.62M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.